These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35089073)

  • 1. Noninvasive Detection of Esophageal Cancer by the Combination of mSEPT9 and SNCG.
    Zhang L; Yang X; Tian Y; Yu Q; Zhou D; Wu Z; Zhao X
    Genet Test Mol Biomarkers; 2022 Jan; 26(1):8-16. PubMed ID: 35089073
    [No Abstract]   [Full Text] [Related]  

  • 2. Opportunistic screening and survival prediction of digestive cancers by the combination of blood
    Song L; Chen Y; Gong Y; Wan J; Guo S; Liu H; Li Y; Zeng Z; Lu Y
    Ther Adv Med Oncol; 2020; 12():1758835920962966. PubMed ID: 33403008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Performance of Methylated
    Tang H; Ma X; Zhou L; Li W; Shu Y; Xu H; Li J; Wang F; Sun F; Duan Y
    Genet Test Mol Biomarkers; 2022 Apr; 26(4):239-248. PubMed ID: 35481971
    [No Abstract]   [Full Text] [Related]  

  • 4. A combination of methylation and protein markers is capable of detecting gastric cancer detection by combined markers.
    Xu J; Song J; Wang T; Zhu W; Zuo L; Wu J; Guo J; Yang X
    Epigenomics; 2021 Oct; 13(19):1557-1570. PubMed ID: 34632818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients.
    Tastekin D; Kargin S; Karabulut M; Yaldız N; Tambas M; Gurdal N; Tatli AM; Arslan D; Gok AF; Aykan F
    Tumour Biol; 2014 Dec; 35(12):11871-7. PubMed ID: 25142230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined phenotype of 4 markers improves prognostic value of patients with colon cancer.
    Liu C; Qu L; Dong B; Xing X; Ren T; Zeng Y; Jiang B; Meng L; Wu J; Shou C
    Am J Med Sci; 2012 Apr; 343(4):295-302. PubMed ID: 22261620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of plasma SEPTIN9 methylation detection for diagnosis and predicting radiosensitivity of esophageal carcinoma].
    Sun Q; Liu J; Fan X; Zhou Y; Wang X; Cui Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(8):1214-1219. PubMed ID: 34549713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma.
    Takemura Y; Ojima H; Oshima G; Shinoda M; Hasegawa Y; Kitago M; Yagi H; Abe Y; Hori S; Fujii-Nishimura Y; Kubota N; Masuda Y; Hibi T; Sakamoto M; Kitagawa Y
    Cancer Med; 2021 Aug; 10(16):5599-5613. PubMed ID: 34245137
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Li B; Huang H; Huang R; Zhang W; Zhou G; Wu Z; Lv C; Han X; Jiang L; Li Y; Li B; Zhang Z
    Dis Markers; 2020; 2020():6289063. PubMed ID: 33178361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.
    Mhawech-Fauceglia P; Wang D; Syriac S; Godoy H; Dupont N; Liu S; Odunsi K
    Gynecol Oncol; 2012 Jan; 124(1):148-52. PubMed ID: 22015044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen.
    Liu C; Dong B; Lu A; Qu L; Xing X; Meng L; Wu J; Eric Shi Y; Shou C
    BMC Cancer; 2010 Jul; 10():359. PubMed ID: 20604972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
    Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
    J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform.
    Schaal K; Hirschfeld M; Bronsert P; Füllgraf H; Jäger M; Herde B; Nöthling C; Mayer S; Erbes T; Stickeler E
    Oncotarget; 2015 Sep; 6(26):22553-63. PubMed ID: 26265438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer.
    Liu C; Shi B; Hao C; Wang Q; Lv Q; Xing N; Shou J; Qu L; Gao Y; Qin C; Zhao J; Shou C
    Oncotarget; 2016 Jul; 7(28):43432-43441. PubMed ID: 27223068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China.
    Gao JJ; Wang YW; Li Y; Wang ZL; Feng A; Li N; Hui LY
    Clin Chim Acta; 2022 Dec; 537():118-126. PubMed ID: 36330944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
    Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
    BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
    Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
    Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma.
    Adams L; Roth MJ; Abnet CC; Dawsey SP; Qiao YL; Wang GQ; Wei WQ; Lu N; Dawsey SM; Woodson K
    Cancer Prev Res (Phila); 2008 Oct; 1(5):357-61. PubMed ID: 19137073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancer.
    Wu K; Huang S; Zhu M; Lu Y; Chen J; Wang Y; Lin Q; Shen W; Zhang S; Zhu J; Shi YE; Weng Z
    Med Oncol; 2013; 30(3):612. PubMed ID: 23696021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients.
    Min L; Zhang C; Ma R; Li X; Yuan H; Li Y; Chen R; Liu C; Guo J; Qu L; Shou C
    BMC Cancer; 2016 Sep; 16(1):717. PubMed ID: 27595752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.